Industry Briefs: Mar. 12, 2012

Article

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Amgen has completed its tender offer for the outstanding shares of Micromet. Read More

Celgene has completed its acquisition of Avila Therapeutics. Read More

EMD Millipore and the Centre for Commercialization of Regenerative Medicine have agreed to develop optimized conditions for bioreactor-based cultivation of stem cells.

Marken plans to open four additional logistics branches in India. Read More

Mylan plans to build a new corporate headquarters near its current location in the Southpointe Office Park located in Cecil Township, Pennsylvania. Read More

SCM Pharma invests in an expansion of its vial-filling capabilities. Read More

Valeant Pharmaceuticals has agreed to acquire certain assets from Gerot Lannach. Read More

Valeant Pharmaceuticals has acquired a 19.9% minority equity investment in Pele Nova Biotecnologia. Read More

People News

Catalent Pharma Solutions has named Jeremie Trochu to the newly created position of vice-president of commercial excellence, effective immediately. Read More

Hovione has appointed Colin Minchom as vice-president of its particle-design business unit. Read More

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content